DE SERVI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 2.697
EU - Europa 1.749
AS - Asia 1.554
SA - Sud America 125
AF - Africa 22
Totale 6.147
Nazione #
US - Stati Uniti d'America 2.652
CN - Cina 889
IE - Irlanda 373
SG - Singapore 332
SE - Svezia 234
DE - Germania 228
UA - Ucraina 226
FI - Finlandia 195
HK - Hong Kong 195
RU - Federazione Russa 172
GB - Regno Unito 131
BR - Brasile 101
IT - Italia 66
VN - Vietnam 44
FR - Francia 32
AT - Austria 29
CA - Canada 23
IN - India 21
MX - Messico 17
JP - Giappone 14
PL - Polonia 14
BE - Belgio 10
AR - Argentina 9
ES - Italia 9
NL - Olanda 9
LT - Lituania 8
TR - Turchia 8
BD - Bangladesh 7
ZA - Sudafrica 7
KR - Corea 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
IQ - Iraq 5
MU - Mauritius 5
CZ - Repubblica Ceca 4
IR - Iran 4
DZ - Algeria 3
EC - Ecuador 3
LV - Lettonia 3
PE - Perù 3
UZ - Uzbekistan 3
JM - Giamaica 2
JO - Giordania 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
PK - Pakistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 6.147
Città #
Chandler 441
Dublin 373
Ashburn 265
Jacksonville 249
Hong Kong 195
Nanjing 175
Dallas 169
Beijing 162
Singapore 121
Boardman 117
Wilmington 107
Ann Arbor 89
New York 87
Los Angeles 77
Helsinki 75
Princeton 75
Nanchang 73
Lawrence 70
Medford 65
Shenyang 64
Munich 63
Hebei 54
Changsha 45
Jiaxing 44
Moscow 41
Houston 39
Hangzhou 37
Tianjin 36
Nuremberg 35
Woodbridge 34
Dearborn 31
Milan 25
Shanghai 25
Redondo Beach 23
Buffalo 21
Verona 18
Fairfield 17
Ho Chi Minh City 16
Turku 15
Warsaw 14
Denver 13
Norwalk 13
Pavia 13
Tokyo 13
Mexico City 12
Santa Clara 12
Stockholm 11
Brussels 10
Montreal 10
Brooklyn 9
Phoenix 9
Vienna 9
Chennai 8
Des Moines 8
Hanoi 8
Jinan 8
Seattle 8
Guangzhou 7
São Paulo 7
Toronto 7
Ankara 6
Boston 6
Falkenstein 6
London 6
Orem 6
Rio de Janeiro 6
San Francisco 6
Atlanta 5
Chicago 5
Guarulhos 5
Hefei 5
Portsmouth 5
Taizhou 5
The Dalles 5
Berlin 4
Borås 4
Columbus 4
Frankfurt am Main 4
Mumbai 4
Ningbo 4
Poplar 4
Redwood City 4
Zhengzhou 4
Biên Hòa 3
Brasília 3
Brno 3
Chongqing 3
Da Nang 3
Johannesburg 3
Lanzhou 3
Manchester 3
Miami 3
Qingdao 3
Riga 3
Shenzhen 3
Sorocaba 3
Tappahannock 3
Tashkent 3
Amman 2
Amsterdam 2
Totale 4.039
Nome #
Causes and clinical implications of premature discontinuation of dual antiplatelet therapy. 132
Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review. 122
Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System. 121
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system 120
Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. 116
Absence of correlation between coronary thrombosis and postatherectomy restenosis 111
Anemia in octogenarians with non-ST elevation acute coronary syndrome: aging or disease? 110
CoreValve implantation for severe aortic regurgitation: a multicentre registry. 110
Causes of death in patients ≥75 years of age with non-ST-segment elevation acute coronary syndrome. 110
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 109
Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure 109
Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis. 108
Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial. 106
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 105
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 104
Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome A Randomized Controlled Trial 102
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus. 101
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 101
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 98
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 96
Does the target vessel impact on results of percutaneous coronary intervention for bifurcation lesions? Insights from the I-BIGIS registry. 95
One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. 94
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 94
Impact of Gene Polymorphisms, Platelet Reactivity, and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 93
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 93
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. 92
Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials. 90
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 90
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 90
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 90
Quality and appropriateness of coronary angioplasty in Lombardy: analysis of data from the registry of the Italian Society of Invasive Cardiology (SICI-GISE)]. 89
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. 88
Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. 88
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor. 88
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology. 87
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention 86
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. 85
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. 84
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 84
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 83
Trilogy: In search of the lost ring. 82
Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes. 82
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. 82
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 82
Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter? 81
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. 81
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. 79
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes - results from the BASKET PROVE trial. 79
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions. 78
Leptin affects the inflammatory response after STEMI 78
How to reduce mortality in ST-elevation myocardial infarction patients treated with primary percutaneous coronary interventions: cut the bleeding. 77
The bivalirudin paradox: high evidence, low use. 76
LombardIMA: a regional registry for coronary angioplasty in ST-elevation myocardial infarction. 76
Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease 75
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. 75
Interplay between Mitral Regurgitation and Transcatheter Aortic Valve Replacement with the CoreValve Revalving System: A Multicenter Registry. 74
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 73
Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the Elderly ACS-2 trial 70
Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes. 69
To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions. 68
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 68
Histopathologic features in atherectomy samples obtained from patient with unstable angina, stable angina and restenosis. Directional Atherectomy Lombardi Group 66
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 62
Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry. 59
Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. 58
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. 56
Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies. 55
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 54
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. 51
How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial? 51
Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors 47
Neutrophil count as a risk factor for cardiovascular diseases: How can we manage it? 32
Percutaneous coronary interventions for stable ischemic heart disease in Italy 32
Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT registry 26
Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties 23
Totale 6.251
Categoria #
all - tutte 25.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 77 5 85 40 75 75 35
2021/2022302 5 3 4 2 5 1 5 24 20 9 44 180
2022/20231.197 178 92 10 93 143 104 0 74 441 6 28 28
2023/2024338 34 79 9 15 28 111 2 22 2 20 9 7
2024/20251.006 24 83 24 18 22 41 42 88 238 28 134 264
2025/20261.234 215 182 247 258 261 71 0 0 0 0 0 0
Totale 6.251